Effective treatment of experimental uveitis with interleukin-1 blockers, CK 123 and CK 124

Journal of Ocular Pharmacology and Therapeutics

Volumn 14, Issue 1, 1998, Pages 31-44

  Xuan, Bo ^a   Chiou, George C Y ^a   Chen, Zhou ^a   Yamasaki, Tetsuo ^b   Okawara, Tadashi ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 BENZYLIDENEHYDRAZINOCOUMARIN; 5 BENZYLIDENEHYDRAZINO 2 METHYLPYRIDAZIN 3(2H) ONE; CK 123; CK 124; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; NONHUMAN; RAT; RNA SYNTHESIS; UVEITIS;

EID: 0031939338     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1998.14.31     Document Type: Article

References (22)

1. Patil, P.N. and Burkman, A.M. Introduction to Ocular Pharmacology and Toxicology, Chapter 8, Greydon Press, Columbus, OH, 1996.
2. Chiou, G.C.Y. and Chang, M.S. Ocular inflammation induced by lens protein and its prevention with new agents. New Trends in Lipid Mediators Research, Lipid Mediators in Eye Inflammation, Bazan, N.G., ed., Karger, Basel, pp. 94-109, 1990.
3. Masuda, K. Anti-inflammatory agents: Non-steroidal anti-inflammatory drugs, Pharmacology of the Eye, Sears, M.L., ed. Springer-Verlag, New York, pp. 539-551, 1984.
4. Braquet, P. Handbook of PAF and PAT Antagonists, CRC Press, Boca Raton, FL, 1991.
5. Melli, M. and Parente, L. Cytokines and Lipocortins in Inflammation and Differentiation, Wiley-Liss, New York, 1990.
6. Dawson, M.M. Lymphokines and Interleukins. CRC Press, Boca Raton, FL, 1991.
7. Bluthe, R.M., Dantzer, R. and Kelley, K.W. Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res. 573:318-320, 1992.
8. Cominelli, F., Nast, C.C., Duchini, LA. and Lee, M. Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65-71, 1992.
9. Coceani, F., Lees, J., Redford, J., and Bishai, I. Interleukin-1 receptor antagonist: effectiveness against interleukin-1 fever. Can. J. Physiol. Pharmacol. 70:1590-1596, 1992.
10. Meyers, K.P., Czachowski, C.L., and Coffey, J.W. Effect of treatment with interleukin-1 receptor antagonist on the development of carrageenan-induced pleurisy in the rat. Inflammation 17:121-134, 1993.
11. Watson, M.L., Smith, D., Boune, A.D., Thompson, R.C., and Westwick, J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 8:365-369, 1993.
12. Conti, P., Reale, M., Panara, M.R., Fridas, S., Placido, F.C., and Barbacane, R.C. Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate. Calcif. Tissue Int. 52:300-304, 1993.
13. Lan, H.Y., Nikolic-Paterson, D.J., Zarama, M., Vannice, J.L., and Atkins, R.C. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int. 43:479-485, 1993.
14. Granowitz, E.V., Porat, R., Mier, J.W., Pribble, J.P., Stiles, D.M., Bloedow, D.C., Catalona, M.A., Wolff, S.M., and Di-Narello, C.A. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 4:353-360, 1992.
15. Chiou, G.C.Y., Yao, Q.S. and Okawara, T, Prevention of ocular inflammation induced by lens protein, endotoxin, and IL-1 blockers. J. Ocular Pharmacol. 10:577-586, 1994.
16. Chiou, G.C.Y., Yao, Q.S., Chang, M.S., and Okawara, T. Prevention and treatment of ocular inflammation with a new class of non-steroidal anti-inflammatory agents. J. Ocular Pharmacol. 10:335-347, 1994.
17. Xiao, J.G., Schwade, N.D., and Chiou, G.C.Y. Mechanisms of antagonism of interleukin-1α by synthetic interleukin-1 blockers. J. Ocular Pharmacol. Ther. 11:373-382, 1995.
18. Chiou, G.C.Y. and Liu, S.X.L. Novel non-arachidonate-mediated, non-steroidal anti-inflammatory agents. Exp. Opin. Invest. Drugs 3:725-732, 1994.
19. Chiou, G.C.Y., Chen, Z., Xuan, B., Yamasaki, T. and Okawara, T. Antagonism of IL-I-induced uveitis with IL-1 blockers. J. Ocular Pharmacol. Ther. in press, 1997.
20. Schwade, N. and Chiou, G.C.Y. The use of trabeculectomy to study the pharmacological modulation of ophthalmic wound healing. J. Ocular Pharmacol. Ther. 11:113-124, 1995.
21. Schwade, N. and Chiou, G.C.Y. Effects of interleukini-1 blockers on ophthalmic wound healing in rabbit model of trabeculectomy. J. Ocular Pharmacol. Ther. 11:125-134, 1995.
22. Yamasaki, T., Kawaminami, E., Yamada, T., Okamoto, Y., Okawara, T., and Furukawa, M. Novel heterocyclization of hydrazinopyridazinones with dimethyl acetylene-dicarboxylate with dehydrogenation and rearrangement. J. Chem. Soc. Perkin Trans. 1:991, 1991.